How many institutions held AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in Q1 2022?

30 institutional investors reported AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

Q: What does CUSIP 00901B105 represent in this 13F holders report?

CUSIP 00901B105 is the security identifier for AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 00901B105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,121,202
Total 13F shares: 6,715,161
Share change: -746,057
Total reported value: $7,116,832
Price per share: $1.06
Number of holders: 30
Value change: -$763,828
Number of buys: 7
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 00901B105:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MORGAN STANLEY	13F	Company	11%	2,040,962	$1,878,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	11%	2,000,285	$1,840,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	4.6%	834,303	$767,000	—	31 Dec 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.9%	705,100	$649,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.1%	372,953	$343,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.7%	301,297	$277,000	—	31 Dec 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	216,000	$199,000	—	31 Dec 2021	13F
Verition Fund Management LLC	13F	Company	0.89%	162,000	$149,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.89%	160,413	$148,000	—	31 Dec 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.64%	116,800	$107,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.49%	88,662	$82,000	—	31 Dec 2021	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.27%	48,450	$45,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.23%	41,052	$37,000	—	31 Dec 2021	13F
Rockefeller Capital Management L.P.	13F	Company	0.22%	40,000	$36,000	—	31 Dec 2021	13F
SeaCrest Wealth Management, LLC	13F	Company	0.21%	38,563	$35,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.21%	37,812	$35,000	—	31 Dec 2021	13F
Virtu Financial LLC	13F	Company	0.21%	37,657	$35,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.15%	27,563	$25,000	—	31 Dec 2021	13F
HighTower Advisors, LLC	13F	Company	0.13%	24,035	$22,000	—	31 Dec 2021	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0.11%	20,000	$18,000	—	31 Dec 2021	13F
LPL Financial LLC	13F	Company	0.09%	16,482	$15,000	—	31 Dec 2021	13F
WINTON GROUP Ltd	13F	Company	0.09%	15,693	$14,000	—	31 Dec 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.09%	15,499	$14,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	15,000	$14,000	—	31 Dec 2021	13F
Community Bank, N.A.	13F	Company	0.07%	13,226	$12,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	12,970	$12,000	—	31 Dec 2021	13F
Traynor Capital Management, Inc.	13F	Company	0.06%	11,777	$10,000	—	31 Dec 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.06%	11,100	$10,000	—	31 Dec 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.06%	11,000	$10,000	—	31 Dec 2021	13F
SNS Financial Group, LLC	13F	Company	0.06%	10,000	$9,000	—	31 Dec 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0.03%	4,671	$4,000	—	31 Dec 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.02%	3,048	$3,000	—	31 Dec 2021	13F
Stephens Consulting, LLC	13F	Company	0.02%	3,000	$2,760	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	2,617	$2,000	—	31 Dec 2021	13F
HOWE & RUSLING INC	13F	Company	0.01%	1,500	$1,000	—	31 Dec 2021	13F
HOEY INVESTMENTS, INC	13F	Company	0.01%	1,000	$1,000	—	31 Dec 2021	13F
TD Waterhouse Canada Inc.	13F	Company	0%	170	$220	—	31 Dec 2021	13F
American Portfolios Advisors	13F	Company	0%	228	$210	—	31 Dec 2021	13F

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q1 2022

As of 31 Mar 2022, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,715,161 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Verition Fund Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, and NORTHERN TRUST CORP. This page lists 30 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

-6

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.